Telemonitoring with SpA-Net

Effectiveness and cost-effectiveness of monitoring spondyloarthritis with the integrated eHealth system SpA-Net: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON25783

Enrollment

200

Registered

2019-07-23

Start date

2020-12-02

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spondyloarthritis Axial and/or peripheral spondyloarthritis, psoriatic arthritis, ankylosing spondylitis

Interventions

Asynchronous telemonitoring (met behulp van SpA-Net) in combinatie met patiënt-geïnitieerde zorg

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible for participation in this study, subjects must meet all of the following criteria: • Adult patient (18+ years) • Diagnosis of SpA according to treating physician • At least 2 years of disease duration, to be familiar with signs, symptoms, and medication • Stable disease, defined as being in a patient acceptable symptom state according to patient AND treating physician (36) AND no treatment change expected in the next few months • Access to a computer, tablet and/or smartphone for the entire duration of the study

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Insufficient mastery of Dutch language • Incompetent to act for oneself • Limited life expectancy • Ongoing (or planned) pregnancy during the study period • Patients participating in other research project(s)

Design outcomes

Primary

Measure	Time frame
At least 25% reduction in the number of scheduled and unscheduled outpatient visits to the rheumatology department in the telemonitoring group compared to the standard care group within a 1-year follow-up period.	—

Secondary

Measure	Time frame
• Non-inferiority of telemonitoring compared to standard care with respect to quality of care and health outcomes. • Non-inferiority with respect to experience with SpA-Net and general rheumatological care. • Association between patient-reported self-management skills and successful application of telemonitoring • Experience with telemonitoring through SpA-Net among care providers • Difference between the populations with regard to healthcare cost per quality adjusted life year (QALY) gained after 1 year • Difference between the populations with regard to societal cost per QALY gained after 1 year	—

Measure

Time frame

• Non-inferiority of telemonitoring compared to standard care with respect to quality of care and health outcomes. • Non-inferiority with respect to experience with SpA-Net and general rheumatological care. • Association between patient-reported self-management skills and successful application of telemonitoring • Experience with telemonitoring through SpA-Net among care providers • Difference between the populations with regard to healthcare cost per quality adjusted life year (QALY) gained after 1 year • Difference between the populations with regard to societal cost per QALY gained after 1 year

—

Contacts

Public ContactKasper Hermans

Maastricht UMC+, department of Internal Medicine, subdivision of Rheumatology

kasper.hermans@mumc.nl0031433884292

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)